Publications:4
Video Visit Available
Accepting New Patients
- Mount Sinai Doctors
- Treats Adults
- Video Visit Available
- Accepting New Patients
Ira A Blaufarb, MD
Cardiovascular Disease (Heart Disease), Nuclear Cardiology
About Me
Dr. Blaufarb is a passionate and gentle physician with a particular interest in women’s cardiac health. His patients love his ability to translate complex cardiac conditions into understandable terms as well as his natural gift to encourage and comfort. Dr. Blaufarb is an avid cyclist with a keen business sense evidenced by his recent completion of the NYU Stern Executive MBA program.
Dr. Blaufarb received his Bachelor of Science from Union College and his Doctor of Medicine from Jefferson Medical College. He completed his residency at Mt. Sinai Hospital in New York, and a fellowship in cardiology at the Albert Einstein College of Medicine. From 1995 to 1996, and Dr. Blaufarb was the Administrative Chief Fellow in the Division of Cardiology at Albert Einstein College of Medicine. Dr Blaufarb is board certified in Cardiovascular Disease and Nuclear Cardiology. In addition to acting as an Associate Professor at Mount Sinai, Dr. Blaufarb is also on staff at Lenox Hill Hospital.
Language
English
Position
ASSOCIATE PROFESSOR | Medicine, Cardiology
Hospital Affiliations
- Mount Sinai Queens
- The Mount Sinai Hospital
Clinical Focus
- Aortic Disease
- Cardiology Second Opinion
- Cardiomyopathy
- Cardiovascular Disease
- Chest Pain
- Congestive Heart Failure
- Coronary Artery Disease
- ECG / EKG
- Endocarditis
- Pericarditis
Education
MD, Thomas Jefferson University
MBA, NYU Stern School of Business
Cardiology Fellowship, Albert Einstein College of Medicine
Medical Internship, The Mount Sinai Hospital
Residency, Internal Medicine
Mount Sinai Hospital
Fellowship, Cardiology
Albert Einstein College of Medicine-Yeshiva University
Certifications
American Board of Internal Medicine
Insurance Information
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.
- 1199 SEIU
- AETNA - Commercial
- AETNA - Medicare
- CIGNA Healthcare
- Centivo
- Elderplan
- EmblemHealth - GHI-PPO
- EmblemHealth - HIP
- EmblemHealth - HIP-Medicare
- Empire Blue Cross Blue Shield - Commercial/Exchange
- Empire Blue Cross Blue Shield - Medicare
- HealthFirst Medicare
- Horizon NJ
- Magnacare-Health Care
- Medicare - NJ
- Medicare - NY
- Multiplan PHCS
- NJ Medicaid
- NY Medicaid
- Oscar
- United Health Care - Commercial
- United Health Care - Empire Plan
- United Health Care - Oxford Care
- United Health Care - Top Tier
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Selected Publications
- Addition of angiotensin II receptor blockade to maximal angiotensin- converting enzyme inhibition improves exercise capacity in patients with severe congestive heart failure. Glenn Hamroff, Stuart D. Katz, Donna Mancini, Ira Blaufarb, Rachel Bijou, Rajoo Patel, Guillaume Jondeau, Maria Teresa Olivari, Sylvia Thomas, Thierry H. Le Jemtel. Circulation
- Angiotensin II-receptor blockade further reduces afterload safely in patients maximally treated with angiotensin-converting enzyme inhibitors for heart failure. Glenn Hamroff, Ira Blaufarb, Donna Mancini, Stuart D. Katz, Rachel Bijou, Guillaume Jondeau, Maria Teresa Olivari, Sylvia Thomas, Thierry H. Lejemtel. Journal of Cardiovascular Pharmacology
- The renin-angiotensin system in left ventricular remodeling. Ira S. Blaufarb, Edmund H. Sonnenblick. American Journal of Cardiology
Patient Experience Star Ratings and Comments
The Patient Experience Star Rating reflects our patients’ perception of how well their Mount Sinai provider communicated with them during an office visit. The Star Rating is based on patient responses to three questions on a patient experience survey, a standardized questionnaire sent to verified patients and distributed by a third party vendor, Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score.
Care Provider’s Explanation
4.8 out of 5
Care Provider’s Concern
4.9 out of 5
Likelihood to Recommend Care Provider
4.8 out of 5
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Blaufarb has not yet completed reporting of Industry relationships.
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.